K Pharmaceuticals

Anavox Pharmaceuticals, based in Madison, WI, specializes in innovative bone health solutions with their flagship product, Bonesse. This game-changing supplement is designed to repair, restore, and maintain bone health by providing optimal bone nutrition through its patented ingredient, GemiCol, combined with essential vitamins D3 and K2. With over a decade of research, Bonesse aims to improve bone strength, increase bone density, and reduce bone loss, ultimately helping to prevent osteoporosis. The product is formulated to holistically support the body's bone activity, offering a superior alternative to traditional calcium supplements by delivering a comprehensive nutrient profile for effective bone remodeling and health maintenance. Generated from the website

King Pharmaceuticals is a vertically integrated pharmaceutical firm that develops, manufactures, markets and sells therapies and technologies for cardiovascular, metabolics, neuroscience, and hospital and acute care. The company has unique strengths in commercialization, advanced clinical development, manufacturing and regulatory affairs. It features various late-stage compounds and branded prescription products and technologies. King s product line includes Altace, Skelaxin, Sonata, Levoxyl, Synercid and auto-injector solutions. The company s facilities produce a range of dosage forms, such as tablets, capsules, liquids, suspensions, solutions, suppositories, creams, ointments and injectables. It is listed on the S&P 500 Index. King Pharmaceuticals operates manufacturing facilities in Bristol, Tenn., Rochester, Mich., St. Louis, St. Petersburg, Fla., and Middleton, Wis.

Gala Biotech, established in 1996, is a business unit of Cardinal Health. The company has more than 40 employees and offers a wide range of capabilities in the fields of molecular biology, vector biology, cell line development, biopharmaceutical manufacturing, protein biochemistry, and quality systems. Gala Biotech uses a gene insertion and expression technology that allows creation of mammalian cell lines for a wide variety of gene products. Additionally, the company produces pharmaceutical and therapeutic proteins for clinical development. Gala Biotech designs tailor development programs for Phase I and II clinical trials in its 43,000-square-foot facility and is located in Middleton, Wis.